论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Wang J, Liu C, Chang X, Qi Y, Zhu Z, Yang X
Received 7 August 2018
Accepted for publication 31 October 2018
Published 4 December 2018 Volume 2018:10 Pages 6641—6647
DOI https://doi.org/10.2147/CMAR.S183043
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Rituraj Purohit
Background: Peritoneal
metastasis frequently occurs in patients with advanced ovarian cancer and is
the main basis for a poor prognosis. The mechanism underlying preferential
ovarian cancer spread to the peritoneum is not well understood.
Methods: Herein,
we investigated the significance and mechanism underlying fibrosis of
mesothelial cells promoting peritoneal implantation of ovarian cancer. We have
assessed the mesothelial cell fibroblast transformation process in
peritoneal tissues of omentum and fibrotic mesothelial cell release of
chemokines to promote dissemination by scanning electron microscopy, ELISA,
Western blot, and Transwell chamber assay.
Results: We showed that
the fibrosis of mesothelial cells exists in the peritoneum of ovarian cancer
patients with peritoneal metastasis. Fibrosis of the mesothelial cells was
induced by TGF-β1, which upregulates the CXCL12–CXCR4 and CXCL16–CXCR6 axes of
mesothelial cells.
Conclusion: CXCL12–CXCR4
and CXCL16–CXCR6 may be important signaling pathways closely involved in
peritoneal metastasis of ovarian cancer that require further investigation. The
findings may lead to developing alternative strategies aimed at preventing and
treating the metastasis of ovarian cancer.
Keywords: ovarian cancer,
peritoneal, mesothelial cell, fibrosis
